NextGen Biomed (XTAE:NXGN) 3-Year EBITDA Growth Rate : -67.40% (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is NextGen Biomed 3-Year EBITDA Growth Rate?

NextGen Biomed's EBITDA per Share for the six months ended in Jun. 2023 was ₪-0.28.

During the past 3 years, the average EBITDA Per Share Growth Rate was -67.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of NextGen Biomed was 65.20% per year. The lowest was -67.40% per year. And the median was 16.10% per year.

Competitive Comparison of NextGen Biomed's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, NextGen Biomed's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NextGen Biomed's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NextGen Biomed's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where NextGen Biomed's 3-Year EBITDA Growth Rate falls into.

NextGen Biomed 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

NextGen Biomed (XTAE:NXGN) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

NextGen Biomed 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of NextGen Biomed's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

NextGen Biomed (XTAE:NXGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NextGen Biomed Ltd (XTAE:NXGN) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Round Tower 22nd Floor, Tel Aviv, ISR, 6701101

Website

http://www.nextgen-biomed.com

NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.